Phase II study of intratumoral injection of rF-TRICOM in patients with metastatic melanoma who have detectable tumor associated T cells.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2014 Biomarkers information updated
- 24 Mar 2010 Actual number of patients (28) added as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.